Molecular Imaging: Page 11

Viennese team presents novel findings on NSCLC patients
By Edna Astbury-Ward, PhD
Austrian researchers have found neoadjuvant chemoimmunotherapy leads to a high rate of pathologic complete remissions in cases of early-stage, non-small cell lung cancer (NSCLC).
February 22, 2024
Radiological response inconsistent with pathological response: 69-year-old patient with non-small cell lung cancer (NSCLC) received a neoadjuvant treatment with three cycles of immune-checkpoint inhibitor therapy plus chemotherapy (ICIT + C, carboplatin/pemetrexed/pembrolizumab). 12 weeks after treatment began, the patient showed complete pathologic response (ypTo, pNo) but only partial radiological response.
Was nuclear medicine adequately consulted on new guidelines?
By Liz Carey
Nuclear medicine physicians have warned of gaps and errors in recommendations for the management of thyroid nodules. They claim they weren't involved enough in the discussion stages.
February 19, 2024
Thyroid 400
Life Molecular and Oryx sign deal to distribute amyloid PET tracer
By AuntMinnie.com staff writers
Life Molecular Imaging has established a partnership with Oryx Isotopes Industrial Company to produce and distribute Neuraceq in Saudi Arabia.
February 7, 2024
Pet Scanner Bore 400
How are clinical staff using ChatGPT at the Charité in Berlin?
By Liana Gruenberg
Dr. Julian Rogasch and his colleague Dr. Imke Schatka explain to Liana Gruenberg about the current and future potential of the ChatPPT AI tool and how it's being used clinically at the world-famous Charité.
February 2, 2024
2024 01 26 Rogasch And Gruenberg
Can ictal SPECT make a comeback in epilepsy patients?
By Will Morton
A feasibility study could revive interest in SPECT seizure imaging to help neurosurgeons guide brain surgery in epilepsy patients.
January 17, 2024
2023 01 16 Ictal Spect Cropped
PET/MRI can help diagnose fevers of unknown origin
By Will Morton
A Czech study has found that PET/MRI shows considerable promise in diagnosing fevers or inflammation of unknown origin and may have advantages over PET/CT.
January 15, 2024
Pet Mri Fuo
InHealth to launch relocatable radioligand therapy service in U.K.
By AuntMinnieEurope.com staff writers
InHealth will soon launch what the company is calling the U.K.'s first relocatable radioligand therapy service for cancer care.
January 12, 2024
Pet Ct Machine 400
PET/CT predicts brain tumors in melanoma patients
By Will Morton
PET/CT scans are showing clinical promise in predicting brain metastasis in melanoma patients. Researchers from Salzburg in Austria have unveiled their latest findings.
January 4, 2024
A 49-year-old patient with primary clinical stage III melanoma underwent F-18 FDG-PET. The primary tumor Breslow thickness was 6.5 mm. On initial F-18 FDG-PET images, this patient had a high SUVmax (52), resulting in limited survival with the occurrence of brain metastasis in the first year of follow-up (horizontal arrow). Notably, during the course of the treatment, the patient underwent surgical removal of the primary tumor as well as lymph node dissection, followed by neoadjuvant radiotherapy and immunotherapy. Image courtesy of Cancers.
New portable PET scanner tested in humans
By Will Morton
Brain imaging with a newly developed portable PET scanner appears feasible, with a comparison to conventional PET imaging revealing similar results in human subjects.
December 29, 2023
A visual abstract describing a comparison between a portable PET scanner and standard PET scanner. Image courtesy of the Journal of Nuclear Medicine.
IBA celebrates sale of the 100th Cyclone Kiube cyclotron
By AuntMinnieEurope.com staff writers
Ion Beam Applications (IBA) is celebrating the sale of the 100th Cyclone Kiube cyclotron.
December 21, 2023
Iba Astro 2019
PET/CT shows impact of different COVID-19 vaccines
By Will Morton
The type of COVID-19 vaccine and the time interval between vaccination and PET/CT scans are key factors in minimizing false interpretations in cancer patients.
December 18, 2023
A 73-year-old woman with a suspicious lung nodule was referred to our division for F-18 FDG PET/CT exam. She was vaccinated four days before PET/CT. The lung nodule did not show any pathological FDG uptake; however, high tracer activity was detected on her right arm, where she was injected, and multiple hypermetabolic lymph nodes in the right axilla (arrows). Moreover, PET/CT showed high tracer activity in the liver (black arrows), spleen (triangular arrows), and bone marrow (small triangular arrows) as the result of systemic immune response after vaccination. The tracer defect in the liver was due to the known cyst. (A) fusion scan, (B) PET, (C) maximum intensity projection. Image courtesy of Scientific Reports.
German team advocates omitting contrast in pediatric lymphoma cases
By Will Morton
F-18 FDG-PET/MRI scans without the use of a contrast agent is recommended for imaging children suffering from lymphoma, say researchers from Düsseldorf University Hospital.
December 8, 2023
Dusseldorf University Hospital. Photo courtesy of Olaf Doering/Alamy Stock Photo.
Previous Page
Page 11 of 124
Next Page